Skip to content

FP7H2020HORIZON

Istituto Europeo di Oncologia SRL

Country
ITItaly
Defence projects
0
Projects, all programmes
70
As coordinator
14
EU contribution (CORDIS)
EUR 31,187,843
Active
2008 to 2025

Projects

70 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
DUPDOWNDeacetylase inhibitors for autism spectrum disorders: an integrated preclinical validation pipeline in brain organoids and in vivo modelsH20202020ParticipantEUR 41,655
oncNGSNGS diagnostics in 21st century oncology: the best, for all, at all timesH20202020Third partyNot stated
METROFOOD-PPMETROFOOD-RI Preparatory Phase ProjectH20202019Third partyNot stated
ATLASAuTonomous intraLuminAl SurgeryH20202019PartnerEUR 0
EPIC-XSEuropean Proteomics Infrastructure Consortium providing AccessH20202019ParticipantEUR 488,125
ITHACAImmuno-targeting of human AML quiescent cells by a novel phage display approach.H20202018CoordinatorEUR 150,000
ChromDesignChromatin architecture and DesignH20202018ParticipantEUR 261,500
EDIReXEurOPDX Distributed Infrastructure for Research on patient-derived cancer XenograftsH20202018ParticipantEUR 211,693
DissectPcGDissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional IdentityH20202017ParticipantEUR 1,170,068
SYSCIDA Systems medicine approach to chronic inflammatory diseaseH20202017ParticipantEUR 396,954
SMARTsurgSMart weArable Robotic Teleoperated SurgeryH20202017ParticipantEUR 127,500
BOUNCEPredicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE BackH20202017ParticipantEUR 385,600
PREFERPatient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966H20202016ParticipantEUR 496,750
MEDICIThe inflammatory gene expression program in macrophages: An integrative approach for the systematic characterization of transcriptional co-regulatorsH20202016CoordinatorEUR 1,377,912
EDC-MixRiskIntegrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive CompoundsH20202015ParticipantEUR 489,000
LIBRALeading Innovative measures to reach gender Balance in Research ActivitiesH20202015ParticipantEUR 218,938
IMMUTRAINTraining Network for the Immunotherapy of CancerH20202015ParticipantEUR 143,367
EUROSTEMCELLEuropean Consortium for Communicating Stem Cell ResearchH20202015ParticipantEUR 0
iManageCanceriManageCancer - Empowering patients and strengthening self-management in cancer diseasesH20202015ParticipantEUR 464,150
Chromatin3DChromatin Dynamics in Development and DiseaseH20202015ParticipantEUR 93,189

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.